Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Plan To Limit Studies Eligible For Pediatric Exclusivity Criticized By Industry, NORD
Oct 08 2025
•
By
Sue Sutter
BPCA pediatric exclusivity and PREA study requirements work together as a carrot and stick.
(Shutterstock)
More from Clinical Trials
More from United States